Maider Medical Industry Equipment Co.Ltd(688310) recently released the annual performance express. In 2021, the company achieved an operating revenue of 3155258 million yuan, an increase of 19.90% compared with the same period last year; The net profit attributable to the owners of the parent company was 628255 million yuan, an increase of 6.35% compared with the same period last year; The net profit attributable to the owners of the parent company after deducting non recurring profits and losses was 560791 million yuan, an increase of 0.81% compared with the same period last year.
The announcement shows that the share based payment expenses of the company during the reporting period were 4.0587 million yuan, and the impact of the expenses included in the recurring profit and loss on the net profit attributable to the owner of the parent company was 3.5249 million yuan. Therefore, the net profit attributable to the owners of the parent company after excluding the impact of share based payment expenses in 2021 was 6635004 million yuan, an increase of 12.32% over the previous year; In 2021, excluding the impact of share based payment expenses, the net profit attributable to the owner of the parent company after deducting non recurring profits and losses was 59.604 million yuan, an increase of 7.15% over the previous year. At the end of the reporting period, the total assets of the company were 8829491 million yuan, an increase of 8.20% compared with the same period last year; The owner’s equity attributable to the parent company was 767467500 yuan, an increase of 4.14% compared with the same period last year; The net assets per share attributable to the parent company increased by 18.08% compared with the same period last year.
It is reported that the overall performance of Maider Medical Industry Equipment Co.Ltd(688310) 2021 has increased, which is mainly due to the steady development of the company’s main business in 2021. The company makes overall planning, orderly production according to orders, and increases R & D investment and product upgrading iteration. The main equipment added in 2021 are safety injection needle automatic assembly machine, insulin syringe and insulin injection needle automatic assembly machine Automatic packaging machine for infusion set, pre filling and sealing syringe assembly line, etc.
